2Meiners S, Eickelberg O. What shall we do with the damaged proteins in lung diseases? Ask the proteasome! [J]. Eur Respir J, 2012[Epub ahead of print].
3Sun Y, Wang J, Liu Y, et al. Results of phase Ⅲ trial of rhendostatin (YH-16) in advanced non-small cell lung cancer (NSCLC) patients [J]. Proc Am Soc Clin Oncol,2005,23 ( 16 Suppl) :7138.